pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›tofacitinib
drug
save

tofacitinib

Phase 1updated 3mo ago
by Biora Therapeutics Inc
Phase 1
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval120 co-mentions · 60 sources
  • drugXELJANZ XR111 co-mentions · 60 sources
  • drugXELJANZ111 co-mentions · 60 sources
  • drugTOFACITINIB CITRATE111 co-mentions · 60 sources
  • drugtofacitinib citrate ER60 co-mentions · 60 sources
  • tagSmall Molecule60 co-mentions · 60 sources
  • drugtofacitinib ER60 co-mentions · 60 sources
  • companyAjanta Pharma Ltd7 co-mentions · 7 sources

all catalysts(0)

nothing on the calendar yet

Trials studying tofacitinib

  • phase4A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)recruitingn=65
  • —Korean Post-marketing Surveillance for Xeljanz XRrecruitingn=200
  • phase3Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitisactive not recruitingn=118
  • —Effects of Tofacitinib on Body Composition, Bone Mineral Density and Bone Marrow Adiposity in Patients With Rheumatoid Arthritis: the TOFAT Projectcompletedn=10
  • phase2Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment With 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitiscompletedn=180
  • phase2A Study to Assess Efficacy and Safety of CGB-500, 1% Tofacitinib Versus an Active Comparator for Atopic Dermatitiscompletedn=3
  • phase3Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritiscompletedn=302
  • —Observational Study To Assess The Effectiveness and Treatment Adherence Of Tofacitinib of Ulcerative Colitis In Clinical Practice In Swedenrecruitingn=120
more trials →

News(0)

no news has mentioned this drug yet

generic
tofacitinib
indication
Ulcerative Colitis
phase
phase_1
Data sources
ClinicalTrials.gov
last refreshed 16m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?